Patents by Inventor Christiane Noeske-Jungblut

Christiane Noeske-Jungblut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thrombin-inhibiting peptides
    Publication number: 20070042959
    Abstract: Peptides of Formula I are useful for therapeutic purposes, among others.
    Type: Application
    Filed: September 19, 2006
    Publication date: February 22, 2007
    Inventors: Christiane Noeske-Jungblut, Ursula Egner, Peter Donner, Wolf-Dieter Schleuning, Wolfram Bode, Pablo Fuentes Prior
  • Thrombin-inhibiting peptides
    Publication number: 20040147442
    Abstract: Peptides of Formula I are useful for therapeutic purposes, among others.
    Type: Application
    Filed: October 29, 2003
    Publication date: July 29, 2004
    Inventors: Christiane Noeske-Jungblut, Ursula Egner, Peter Donner, Wolf-Dieter Schleuning, Wolfram Bode, Pablo Fuentes Prior
  • Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
    Patent number: 5882887
    Abstract: The invention provides a process of manufacture of a recombinant protein called Asp-Pallidipin. Asp-Pallidipin inhibits the collagen-induced platelet aggregation of mammalian platelets. The Asp-Pallidipin comprises(i) a protein (Pallidipin) selected from the group of Pallidipin proteins, and(ii) the amino acid aspartic acid,wherein the aspartic acid is connected by a peptide bond with the N-terminal end of Pallidipin.
    Type: Grant
    Filed: March 11, 1997
    Date of Patent: March 16, 1999
    Assignee: Schering Aktiengesellschaft
    Inventors: Christiane Noeske-Jungblut, Andreas Becker, Bernard Haendler
  • Thrombin inhibitor from the saliva of protostomia
    Patent number: 5876971
    Abstract: The invention relates to a natural protein or a protein that can be synthetically produced, which is a thrombin inhibitor and can be isolated from the saliva of insects which suck the blood of mammals. Preferred is the Triatoma pallidipennis insect. The protein is used for the treatment of thromboses or unstable angina or arteriosclerosis, or for the prevention of a reblockage of vessels after PTCA/PTA or for the prevention of blood clotting in hemodialysis.
    Type: Grant
    Filed: August 24, 1995
    Date of Patent: March 2, 1999
    Assignee: Schering Aktiengesellschaft
    Inventors: Christiane Noeske-Jungblut, Wolf-Dieter Schleuning, Alejandro Alagon, Lourival Possani, Delia Cuevas-Aguierre, Peter Donner, Bernard Haendler, Ulrike Hechler
  • Collagen-induced platelet aggregation inhibitor
    Patent number: 5756454
    Abstract: The invention provides a protein which inhibits collagen-induced platelet aggregation, derived from Triatoma pallidipennis, and derivatives thereof. The protein is useful for inhibition of collagen-induced human platelet aggregation or of cancer with metastatic tumor cells.
    Type: Grant
    Filed: March 7, 1994
    Date of Patent: May 26, 1998
    Assignee: Schering Aktiengesellschaft
    Inventors: Christiane Noeske-Jungblut, Bernard Haendler, Joern Reiner Kraetzschmar, Wolf-Dieter Schleuning, Alejandro Alagon, Lourival Possani, Delia Cuevas-Aguirre
  • Collagen-induced platelet aggregation inhibitor
    Patent number: 5723312
    Abstract: The invention provides a protein which inhibits collagen-induced platelet aggregation, derived from Triatoma pallidipennis, and derivatives thereof. The protein is useful for inhibition of collagen-induced human platelet aggregation or of cancer with metastatic tumor cells.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 3, 1998
    Assignee: Schering Aktiengesellschaft
    Inventors: Christiane Noeske-Jungblut, Bernard Haendler, Joern Reiner Kraetzschmar, Wolf-Dieter Schleuning, Alejandro Alagon, Lourival Possani, Delia Cuevas-Aguirre